Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties 4 min read Healthcare Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties News Head Business June 21, 2021 ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra [India]: According to...Read More
News Head Business